Medical Device Recalls since November 03, 2006 (Free subscription) | yesterday
Stryker Medical Stair-PRO Stair Chair with wheels and a track system, patient transport device, Model 6252.
PR News Wire (Free subscription) | yesterday
NATICK, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced its schedule of events at the 38th annual Global Congress for Minimally Invasive Gynecology (AAGL), which runs from November 15-19 in Orlando, Florida. Results from two clinical studies will be presented featuring the Company's Urology/Gynecology products, including pelvic floor reconstruction...
Red Orbit (Free subscription) | yesterday
NATICK, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced its schedule of events at the 38th annual Global Congress for Minimally Invasive Gynecology (AAGL), which runs from November 15-19 in Orlando, Florida.
MassDevice - Medical device news, information and jobs... (Free subscription) | yesterday
The British orthopedics giant posts $128 million in net profits during the third quarter, despite a 2 percent slide in Q3 revenues. Smith & Nephew plc 's net profits rose 73 percent during the third quarter, despite a slight downturn in revenues, as the company's cost-cutting measures bear fruit. The British orthopedics giant posted sales of $915 million during the three months ended Sept. 26,...
NewsInferno (Free subscription) | yesterday
Last year we wrote that a prominent physician from the Minneapolis Heart Institute Foundation had expressed concern about test guidelines for a next-generation heart defibrillator under development at the time by Medtronic, Inc., Boston Scientific Corporation, and St. Jude Medical, Inc. Now, Bloomberg News is reporting that Boston Scientific has agreed to pay nearly $300 [...]
PR News Wire (Free subscription) | yesterday
NATICK, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of its COGNIS® cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN® implantable cardioverter defibrillator (ICD) in Japan. These devices were approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) in August and received reimbursement approval in...
Red Orbit (Free subscription) | yesterday
NATICK, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of its COGNIS® cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN® implantable cardioverter defibrillator (ICD) in Japan.
GuruFocus Updates (Free subscription) | 11/08/2009
By gurujk. This is the group of companies who raised their dividend during the week: Questar Corp ( STR ), Stryker Corporation ( SYK ), Middlesex Water Company ( MSEX ), Inergy Holdings GP LLC ( NRGP ) Read more » »
Financial Times (Free subscription) | 11/07/2009
The medical device market is beginning to stabilise, according to Smith & Nephew, amid signs of a pick-up in its US volumes in the third quarter. However, the group,...
DeviceSpace (Free subscription) | 11/06/2009
LONDON--(Marketwire - November 06, 2009) - Highlighted Links RNS Market News Smith & Nephew Q3 Results - continued strong profit performance6 November 2009Smith...
DeviceSpace (Free subscription) | 11/06/2009
Reuters -- Medical device maker Boston Scientific Corp reached an agreement with the U.S. Department of Justice related to product recalls issued by its Guidant subsidiary, and will record a third-quarter charge of $294 million, the company said in a government filing.
PR News Wire (Free subscription) | 11/06/2009
NATICK, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales occurred prior to Boston Scientific's 2006 acquisition of Guidant.
Red Orbit (Free subscription) | 11/06/2009
NATICK, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005.
Market Watch (Free subscription) | 11/06/2009
LONDON (MarketWatch) -- Orthopedics firm Smith & Nephew said Friday that its third-quarter net profit rose to $128 million, from $74 million last year. Revenue declined to $915 million, from $930 million a year ago, hit by adverse currency movements. "Market conditions remain challenging, but are showing some early signs of stabilizing," the firm said. It said that overall revenue guidance...
The Earth Times Online Newspaper (Free subscription) | 11/03/2009
London, UK -- 11/03/09 -- Smith & Nephew plc 3 November 2009 Smith & Nephew plc - Transaction in Own Shares Smith & Nephew plc announces that on 2 November 2009 it transferred a total of 571,733 ordinary shares of USD0.20..
The 3 latest articles published by users on Medical Products and Supplies :
aarkstore | 07/29/2009
Stryker Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. Stryker Corporation - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Stryker is one of the world's leading medical technology companies engaged in the development,...
aarkstore | 07/25/2009
Bausch & Lomb Incorporated Medical Equipment Company Share Analysis Summary This report is an essential source for data, analysis and strategic insight into Bausch & Lomb Incorporated. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company’s business structure and operations, history and...
aarkstore | 07/22/2009
Summary Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marketing of nucleic acid tests (NATs), principally used to diagnose human diseases and screen donated human blood. The company principally operates in North America. It is headquartered in California, United States and employs 1,049 people. The company’s subsidiaries include Gen-Probe Sales & Service, Inc., Delaware;...
Videos